COVID-19 and Inflammatory Bowel Disease.
Gastroenterol Clin North Am
; 52(1): 103-113, 2023 03.
Article
in English
| MEDLINE | ID: covidwho-2282929
ABSTRACT
The COVID-19 pandemic caused by the SARS-CoV-2 virus represents an unprecedented global health crisis. Safe and effective vaccines were rapidly developed and deployed that reduced COVID-19-related severe disease, hospitalization, and death. Patients with inflammatory bowel disease are not at increased risk of severe disease or death from COVID-19, and data from large cohorts of patients with inflammatory bowel disease demonstrate that COVID-19 vaccination is safe and effective. Ongoing research is clarifying the long-term impact of SARS-CoV-2 infection on patients with inflammatory bowel disease, long-term immune responses to COVID-19 vaccination, and optimal timing for repeated COVID-19 vaccination doses.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Inflammatory Bowel Diseases
/
COVID-19
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Gastroenterol Clin North Am
Journal subject:
Gastroenterology
Year:
2023
Document Type:
Article
Affiliation country:
J.gtc.2022.10.005
Similar
MEDLINE
...
LILACS
LIS